Sunday, February 25, 2018 6:39:36 PM
LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, continues its push into the medical and recreational marijuana business to become the premier supplier for genetics cloning. The company announced today that agreements have been made with a group of private investors to provide funding and equipment lease financing for future projects. Additionally, Bill Hodson, CEO of LiveWire, has been appointed to the action committee for the Inland Empire chapter of NORML, the National Organization to Reform Marijuana Laws.
My messages contain many opinions. Please do your own research
and validation.
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM